Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on Ravulizumab for Children with IgA Nephropathy (Ages 2-17)
ItalyStudy on the Effectiveness and Safety of IMVT-1402 for Adults with Graves' Disease
BelgiumLong-Term Safety Study of Inhaled Pirfenidone for Patients with Progressive or Idiopathic Pulmonary Fibrosis
BelgiumStudy on the Safety of Using Autologous Stromal Vascular Fraction Cells and Micrograft for Treating Hard-to-Heal Ano-Perineal Fistulas in Crohn's Disease Patients
FranceComparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
CzechiaStudy on Immune Response to Recombinant Zoster Vaccine in Rheumatic Disease Patients Using Baricitinib, Tofacitinib, or Methotrexate
FranceStudy on the Effects and Safety of Rituximab and Sodium Chloride in Patients with Active Systemic Sclerosis
The NetherlandsEvaluation of remibrutinib (LOU064) effectiveness and safety in adult patients with chronic urticaria: A 12-week placebo-controlled study
FranceStudy of 18F-AlF-FAPI-74 PET/CT imaging compared to standard 18F-FDG PET/CT in patients with fever of unknown origin, IgG4-related disease, and axial spondyloarthritis
BelgiumStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
BelgiumStudy on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites
PortugalStudy on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites
PortugalThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
